Tag: respiratory disease
Australia invests in local manufacturing of AI tools for respiratory disease
Australian health technology company Diag-Nose.io has secured $3 million in federal funding to advance local manufacturing and clinical validation of an artificial intelligence-powered diagnostic platform designed to improve treatment of respiratory disease.
Featured Article
From cost exposure to cost control: Using energy flexibility to protect margins
Electricity price volatility is reshaping the cost base of Australian manufacturing, challenging long-held assumptions that energy can be treated as a stable operational input.
